Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-alpha or interleukin-6.
Daily administration of an escalating dose of tumour necrosis factor-alpha (TNF-alpha) to female NMRI mice caused a progressive loss of body weight representing 12% of the original weight over a 6-day period. Weight loss was associated with a decreased food intake and pair-fed controls exhibited a weight loss of similar magnitude to that caused by TNF-alpha. However, weight loss in animals bearing a murine adenocarcinoma (MAC16) occurred without a change in energy intake and thus differed from that produced by TNF-alpha. Anti-TNF-alpha monoclonal antibodies at levels capable of protecting mice against lethal endotoxaemia were ineffective in reversing weight loss in animals bearing the MAC16 tumour and had no effect on the increase in tumour volume. Circulating levels of interleukin-6 were not elevated in animals bearing the MAC16 tumour and with a weight loss between 1.8 and 5.4 g. These results suggest that these cytokines are not involved in the cachexia produced by this murine tumour.
Mulligan
H D
HD
Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.
Mahony
S M
SM
Ross
J A
JA
Tisdale
M J
MJ
D000230:Adenocarcinoma / Q000503:physiopathology*; D000704:Analysis of Variance; D000818:Animals; D002100:Cachexia / Q000209:etiology* / Q000503:physiopathology; D003110:Colonic Neoplasms / Q000503:physiopathology*; D004195:Disease Models, Animal; D005260:Female; D015850:Interleukin-6 / Q000502:physiology*; D051379:Mice; D008815:Mice, Inbred Strains; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*; D015431:Weight Loss
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha